ArticleFrontiers in oncology2021

Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors.

Marta Opalińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.